Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

IIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib Therapy × anlotinib × 30 days × Clear all

Sponsor

Conditions

Whole-Brain Radiotherapy 1 Thyroid Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Leiomyosarcoma 1 Carcinoma, Renal Cell 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡